文献速递胸部CT

2019冠状病毒病患者的胸部CT特征与疾病进展

Chest CT features and progression of patients with coronavirus disease 2019.
PubMed 文献 · Br J Radiol · 2020-11-13

该回顾性单中心研究纳入49例成人COVID-19确诊患者,分析薄层胸部CT特征与疾病进展,比较普通型与重型/危重型患者的临床及影像表现。重型和危重型患者更常出现磨玻璃影伴实变、纤维化及五叶受累,CT严重度评分和MuLBSTA评分更高,MuLBSTA评分与入住ICU正相关。

要点

  • 重型和危重型患者更常出现磨玻璃影伴实变(86% vs 普通型54%)及纤维化(79% vs 43%)。
  • 重型和危重型患者CT严重度评分5.43±2.38 vs 普通型3.37±2.40(p<0.001)。
  • MuLBSTA评分与入住ICU正相关(p=0.005,r=0.351)。

核心结论

  • 重型和危重型患者肺部病变更严重,常表现为磨玻璃影伴实变。
  • CT严重度评分和MuLBSTA评分可能有助于评估COVID-19的严重程度和进展。

研究设计与样本

  • 回顾性单中心研究,纳入49例成人COVID-19确诊病例,包括普通型、重型和危重型。
  • 评估薄层胸部CT特征及疾病进展,比较不同严重程度患者的临床和胸部影像表现。
  • 计算CT严重度评分和MuLBSTA评分(死亡风险预测评分)。

关键影像表现/征象

  • 98%的患者CT可见纯磨玻璃影。
  • 重型和危重型患者中86%表现为磨玻璃影伴实变,普通型患者中为54%。
  • 重型和危重型患者中79%出现纤维化,普通型患者中为43%。
  • 重型和危重型患者较普通型患者更易出现五叶受累(p=0.002)。

诊断标准与关键数值

  • 重型和危重型患者CT严重度评分为5.43±2.38,普通型为3.37±2.40(p<0.001)。
  • 重型和危重型患者MuLBSTA评分为10.21±3.83,普通型为4.63±3.43(p<0.001)。
  • MuLBSTA评分与入住ICU正相关(p=0.005,r=0.351)。
  • 19例患者接受三次CT扫描,第一次与第二次间隔4[4,8]天,第二次与第三次间隔3[2,4]天。
  • 第三次CT随访所见较第二次有更大改善(p=0.002)。

临床应用与阅片要点

  • 胸部CT可用于评估COVID-19的影像学特征并动态观察疾病进展。
  • 作者认为,考虑到COVID-19的凝血功能障碍,MuLBSTA评分可能需要更新以增加对COVID-19的新认识。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Coronavirus disease 2019 (COVID-19) is a major public health emergency. It poses a grave threat to human life and health. The purpose of the study is to investigate the chest CT findings and progression of the disease observed in COVID-19 patients.

METHODS: Forty-nine confirmed cases of adult COVID-19 patients with common type, severe and critically severe type were included in this retrospective single-center study. The thin-section chest CT features and progress of the disease were evaluated. The clinical and chest imaging findings of COVID-19 patients with different severity types were compared. The CT severity score and MuLBSTA score (a prediction of mortality risk) were calculated in those patients.

RESULTS: Among the 49 patients, 35 patients (71%) were common type and 14 patients (28%) were severe and critically severe type. Nearly all patients (98%) had pure ground-glass opacities (GGO) in CT imaging. Of the severe and critically severe type patients, 86% exhibited GGO with consolidation, in comparison with 54% of the patients with common type. Fibrosis presented in 79% of the severe and critically severe type patients and 43% of the common type patients. The severe and critically severe type patients were significantly more prone to experience five-lobe involvement compared to the common type patients (p = 0.002). The severe and critically severe type patients also had higher CT severity and MuLBSTA scores than the common type patients (5.43 ± 2.38 vs 3.37 ± 2.40, p < 0.001;and 10.21 ± 3.83 vs 4.63 ± 3.43, p < 0.001, respectively). MuLBSTA score was positively correlated with admittance to the intensive care unit (p = 0.005, r = 0.351). Nineteen patients underwent three times CT scan. The interval between first and second CT scan was 4[4,8] days, second and third was 3[2,4] days. There were greater improvements in the third CT follow-up findings compared to the second (p = 0.002).

CONCLUSIONS: The severe and critically severe type patients often experienced more severe lung lesions, including GGO with consolidation. The CT severity score and MuLBSTA score may be helpful for the assessment of COVID-19 severity and progression.

ADVANCES IN KNOWLEDGE: Chest CT has the value of evaluated radiographical features of COVID-19 and allow for dynamic observation of the disease progression. Considering coagulation disorder of COVID-19, MuLBSTA score may need to be updated to increase new understanding of COVID-19.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Xie L, Hou K, Xu H, et al. Chest CT features and progression of patients with coronavirus disease 2019. Br J Radiol. 2020. PMID: 33186052. doi:10.1259/bjr.20200219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。